2014, № 12 (173)

1. Morphological and functional evaluation of the macula in patients with diabetes mellitus after cataract surgery / V.V. Egorov [et al.] // Vestn. Ophthalmol. — 2008. — №4. — P. 22–25.

2. Optic coherent tomography in patients with immature cataract and pseudophakia / A.A. Shpak [et al.] // Vestn. Ophthalmol. — 2006. — 122(4). — P. 18–20.

3. Alio, J.L. Minimizing Incisions and Maximizing Outcomes in Cataract Surgery / J.L. Alio, I.H. Fine. — Springer-Verlag GmbH. — 2009. — P. 314

4. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification / D.R. Almeida [et al.] // J Cataract Refract Surg. — 2012. — 38(9). — P. 1537–1543.

5. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema / M. Cellini [et al.] // BMC Ophthalmol. — 2008. — Vol. 8. — P. 5

6. Evolution of cataract surgery: smaller incision — less complications / V. Draganic [et al.] // Vojnosanit Pregl. — 2012, May. — 69(5). — P. 385–388. (Serbian).

7. Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls / U. Eriksson [et al.] // Graefes Arch ClinExp Ophthalmol. — 2011. — 249. — P. 349–359.

8. Stewart, M.W. Corticosteroid use for diabetic macular edema: old fad or new trend? / M.W. Stewart // CurrDiab Rep. — 2012. — 12(4). — P. 364–375.

9. A randomized, masked comparison of topical ketorolac 0,4% plus steroid vs. steroid alone in low-risk cataract surgery patients / J.R. Wittpenn [et al.] // Am J Ophthalmol. — 2008. — 146(4). — P. 554–560.

About this article